Treatment of visceral leishmaniasis (kala-azar) with aminosidine (= paromomycin)-antimonial combinations, a pilot study in Bihar, India

Authors:
  • POP. Olliaro
    P. Olliaro
  • SGS. Gothoskar
    S. Gothoskar
  • SBS. Bhowmick
    S. Bhowmick
  • BCB.K. Choudhury
    B.K. Choudhury
  • SPS. Prasad
    S. Prasad
  • MKM. Kumar
    M. Kumar
  • BVB.B. Verma
    B.B. Verma

Abstract
A 20 d drug regimen of aminosidine (= paromomycin) at 12 mg/kg/d in combination with sodium stibogluconate at 20 mg/kg/d proved efficacious and well-tolerated in patients with visceral leishmaniasis in the State of Bihar, India. Eighteen of 22 evaluable patients achieved an ultimate cure. The remaining 4 patients, although not cleared of parasites, had their parasite grade reduced and also improved clinically. This confirms prior findings in Kenyan patients with kala-azar, and indicates that this regimen is a valid alternative to antimonial compounds alone in the State of Bihar, where cases of kala-azar not responding to antimonial drugs and intolerant of pentamidine are increasingly recorded.